Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chutes and Ladders
Biotech
Former FDA leader takes new biotech Turn—Chutes & Ladders
Former FDA leader takes new biotech Turn. Amgen lures back exec as new finance chief. Antag tags obesity leader as new CEO.
Darren Incorvaia
,
Zoey Becker
May 22, 2026 8:30am
AC Immune CEO bids adieu—Chutes & Ladders
May 15, 2026 8:30am
Biopharma veteran takes her CEO Cue—Chutes & Ladders
May 8, 2026 8:30am
CBER chief Prasad steps aside, deputy takes the reins
May 1, 2026 9:58am
Astellas appoints new top strategist—Chutes & Ladders
May 1, 2026 8:30am
Helus CEO out after two months—Chutes & Ladders
Apr 24, 2026 8:30am